Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

3.48
BATS BZX Real-Time Price
As of 11:07am ET
 +0.18 / +5.45%
Today’s Change
3.22
Today|||52-Week Range
9.40
-24.68%
Year-to-Date

Today’s Trading

Previous close3.30
Today’s open3.30
Day’s range3.30 - 3.51
Volume9,677
Average volume (3 months)645,100
Market cap$218.5M
Data as of 11:07am ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+53.44%
Earnings growth (this year)-10.25%
Earnings growth (next 5 years)+74.00%
Revenue growth (last year)+4,327.38%
P/E ratioNM
Price/Sales3.73
Price/Book7.80

Competitors

 Today’s
change
Today’s
% change
BDSIBioDelivery Sciences...0.000.00%
ALRNAileron Therapeutics...+0.42+7.84%
ADMPAdamis Pharmaceutica...+0.03+0.70%
OCXOncoCyte Corp-0.18-7.45%
Data as of 11:09am ET, 04/25/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$35.4M
Annual profit (last year)-$17.4M
Net profit margin-49.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Executive VP, Chief Operating &
Financial Officer
Keith W. Marshall
Corporate headquarters
San Diego, California

Forecasts